Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 10.90
+0.08 (0.74%)
Aug 29, 2025, 10:45 AM CST
Zhejiang Hisun Pharmaceutical Company Description
Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China.
The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others.
The company also exports its products to approximately 70 countries worldwide. The company was founded in 1956 and is headquartered in Taizhou, China.
Zhejiang Hisun Pharmaceutical Co., Ltd.
| Country | China |
| Founded | 1956 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 7,994 |
| CEO | Weihong Xiao |
Contact Details
Address: No. 46, Waisha Road Taizhou, 318000 China | |
| Phone | 86 576 8882 7890 |
| Website | hisunpharm.com |
Stock Details
| Ticker Symbol | 600267 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE0000013Z2 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Weihong Xiao | Chief Executive Officer and Chairman |
| Hong Shun Jin | Senior Vice President |
| Zhiqing Yang | Senior Vice President |
| Jiaqiu Du | Senior Vice President and Director |
| Xi Fei Shen Ph.D. | Secretary of the Board |